Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Pharmacovigilance Global Landscape, 2014

May 14 – May 29, 2014

This recorded webinar series offers unparalleled access to key thought leaders in today's pharmacovigilance and drug safety landscape. The presenters share their perspectives and insights on key topics such as enhancing communication channels, Adverse Drug Reaction Management and best practices in Latin America.

The following sessions were presented (60 minutes each):

Who Attended?

Directors, Managers, Heads of, Officers, Scientists, and Specialists in:

  • Pharmacovigilance
  • Drug Safety
  • Product Safety
  • Clinical Safety
  • Regulatory Affairs
  • Data Management
  • PV Auditing
  • Global Safety
  • Medical Information
  • Medical Coding

Pharmacovigilance Global Landscape 2014:


Wednesday, May 14, 2014 @ 9:00am EDT

Webinar 1: ADR Management and Reporting to EudraVigilance

Adverse reactions to drugs are unintended or undesired effects of a drug therapy that may significantly influence management decisions. Predictable adverse drug reactions are common. These reactions are dose dependent or...

Marcin Marciniak
Director Drug Safety & Pharmacovigilance / Deputy EU QPPV
PregLem SA

Bio: Dr. Marciniak is a highly versatile executive with extensive sales & marketing, scientific and business development experience. He joined PregLem SA in 2010, where he is responsible for supporting a European Centrally Authorised Product registration, management of...


Wednesday, May 21, 2014 @ 4:30pm EDT

Webinar 2: Pharmacovigilance and Best Practices in Latin America: An Overview on Safety Reporting, ADR Management & Scope of ANVISA

The presenter will examine emerging economies, including Latin America. The emerging pharmaceutical market economies, which include Brazil, India, Russia, Argentina, Egypt, Indonesia, Mexico, Pakistan, Poland, Romania, South Africa, Thailand, Turkey, Ukraine, Venezuela, and Vietnam, accrued one fifth of global 2011 pharmaceutical expenditures. The Latin American Study of Adverse Events (IBEAS) is a study on ...

    Fernando Pereira
    Pharmacovigilance Manager
    Merck Sharp & Dohme

    Bio: Fernando Pereira has 22 years of pharmacovigilance experience in Brazil, is a former professor of pharmacology and has worked in sentinel hospitals and pharmaceutical companies. He has expertise in pharmacovigilance within a national market, with active participation in pharmaceutical associations...

    Thursday, May 29, 2014 @ 2:30pm EDT

    Webinar 3: Medical Information Then and Now: Leveraging Technology to Enhance Customer Experience

    High quality up to date information about medicines is essential for their safe and effective use in treating patients. Pharmaceutical companies’ medical information departments are a leading source for such information and should be viewed as the most reliable source for medical information on their products....

    Marie-Ange Noue
    Local Medical Information Officer & Deputy Local Drug Safety Officer
    EMD Serono

    Bio: Dr Noue completed her undergraduate studies at Pierre and Marie Curie university in Paris, France, followed by a masters and doctorate degree in Chemistry at the university of Houston, in Texas...


    Share this:

    Honeycomb Worldwide Inc., 94 Cumberland Street, Suite 311, Toronto, ON, M5R 1A3, Canada


    Tweet #eCongress

    Copyright © 2016-2017 Honeycomb Worldwide Inc.